GlobeNewswire: Warrants And Certificates Contains the last 10 of 5002 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T00:06:33ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/28/2854089/0/en/Cancellation-of-Listing-of-DSO-D-Shares-and-Cessation-of-Trading.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesCancellation of Listing of DSO D Shares and Cessation of Trading2024-03-28T13:16:01Z<![CDATA[THAMES VENTURES VCT 2 PLCDSO D SHARE CLASSLEI: 21380035MV1VRYEXPR95]]>https://www.globenewswire.com/news-release/2024/03/27/2853650/0/en/Gross-Proceeds-Close-of-4M-CAD-Generated-for-NurExone-From-Warrants-Exercise.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesGross Proceeds Close of $4M CAD Generated for NurExone From Warrants Exercise2024-03-27T21:05:00Z<![CDATA[TORONTO and HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), is pleased to announce that, the Company completed a combined exercise and expiration of 12,682,340 common share purchase warrants issued pursuant to a private placement of units that closed on June 15, 2022.]]>https://www.globenewswire.com/news-release/2024/03/26/2852457/0/en/Hapbee-Announces-Closing-of-Private-Placement.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesHapbee Announces Closing of Private Placement2024-03-26T13:30:00Z<![CDATA[Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing]]>https://www.globenewswire.com/news-release/2024/03/25/2851541/0/en/REE-Automotive-P7-C-Receives-CARB-Certifications.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesREE Automotive P7-C Receives CARB Certifications2024-03-25T12:00:00Z<![CDATA[• Powered by REE P7-C electric truck is eligible for sale in California]]>Powered by REE P7-C electric truck is eligible for sale in California REE Automotive's P7-Chttps://www.globenewswire.com/news-release/2024/03/20/2849062/0/en/Nevada-Exploration-Closes-Oversubscribed-605-000-Financing.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesNevada Exploration Closes Oversubscribed $605,000 Financing2024-03-20T01:38:37Z<![CDATA[VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- Nevada Exploration Inc. (“NGE” or the “Company”) (TSX-V:NGE; OTCQB:NVDEF) is pleased to announce that it has closed the previously announced private placement offering (the “Offering”), pursuant to which it has issued 5,500,000 units (the “Units”) at a price of $0.11 per Unit, for gross proceeds of $605,000 - an increase of $55,000 from the $550,000 contemplated in the news release dated February 20, 2024.]]>https://www.globenewswire.com/news-release/2024/03/19/2848840/0/en/C3is-Inc-Announces-Closing-of-6-0-Million-Underwritten-Public-Offering.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesC3is Inc. Announces Closing of $6.0 Million Underwritten Public Offering2024-03-19T16:44:14Z<![CDATA[ATHENS, Greece, March 19, 2024 (GLOBE NEWSWIRE) -- C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing dry bulk and crude oil tanker seaborne transportation services, today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately $6.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering consisted of 120,000,000 Common Units or Pre-Funded Units, each consisting of one share of common stock (“Common Share”) or Pre-Funded Warrant, one half of a Class C-1 Warrant to purchase one Common Share at an exercise price of $0.075 per share (or 150% of the price of each Common Unit sold in the offering) or pursuant to an alternative cashless exercise option, which warrant will expire on the five-year anniversary of the original issuance date (the "Class C-1 Warrants") and one Class C-2 Warrant to purchase one Common Share at an exercise price of $0.085 per share (or 170% of the price of each Common Unit sold in the offering) which warrant will expire on the five-year anniversary of the original issuance date (the "Class C-2 Warrants" and together with the Class C-1 Warrants, the "Warrants"). The purchase price of each Common Unit was $0.05, and the purchase price of each Pre-Funded Unit was $0.04 (which is equal to the public offering price per Common Unit minus $0.01). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.]]>https://www.globenewswire.com/news-release/2024/03/19/2848583/0/en/Fate-Therapeutics-Announces-Pricing-of-100-Million-Underwritten-Offering-and-Concurrent-Private-Placement.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesFate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement2024-03-19T12:44:41Z<![CDATA[SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced the pricing of an underwritten offering of 14,545,454 shares of its common stock at an offering price of $5.50 per share. The offering includes participation from new and existing institutional investors, including Adage Capital Partners LP., Boxer Capital, Deep Track Capital, OrbiMed, Suvretta Capital and a life-sciences focused investor.]]>https://www.globenewswire.com/news-release/2024/03/18/2848195/0/en/Greenridge-Exploration-Announces-Closing-of-Private-Placement-for-Gross-Proceeds-of-CDN-3-500-455-12.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesGreenridge Exploration Announces Closing of Private Placement for Gross Proceeds of CDN $3,500,455.122024-03-18T21:00:00Z<![CDATA[THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES]]>https://www.globenewswire.com/news-release/2024/03/15/2846821/0/en/Mendus-major-shareholders-and-members-of-the-Board-of-Directors-and-Management-declare-their-intention-to-exercise-warrants-of-series-TO3.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesMendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO32024-03-15T07:05:00Z<![CDATA[Press Release]]>https://www.globenewswire.com/news-release/2024/03/15/2846821/0/sv/Mendus-erh%C3%A5ller-avsiktsf%C3%B6rklaringar-fr%C3%A5n-st%C3%B6rre-%C3%A4gare-och-styrelse-samt-bolagsledning-avseende-nyttjande-av-teckningsoptioner-av-serie-TO3.html?f=22&fvtc=1&fvtv=Warrants%20And%20CertificatesMendus erhåller avsiktsförklaringar från större ägare och styrelse samt bolagsledning avseende nyttjande av teckningsoptioner av serie TO32024-03-15T07:05:00Z<![CDATA[Pressmeddelande]]>